Stephen A. Sherwin, Director at NEUROCRINE BIOSCIENCES INC (NBIX), sold 25,000 shares at $163.81 ($4.1M) on 2026-06-05, disclosed to the SEC on 2026-06-09.
Scheduled sale ($4.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $163.81 | 7,883 | $1.3M | 31.2% |
| 2 | $164.44 | 2,549 | $419K | 10.1% |
| 3 | $165.79 | 6,896 | $1.1M | 27.7% |
| 4 | $166.56 | 5,829 | $971K | 23.5% |
| 5 | $167.31 | 1,843 | $308K | 7.5% |
| Total | $165.32 avg | 25,000 |
| $4.1M |
| 100% |
| Filing → |
| NBIX | SELL | 2024-05-30 | $5.3M | — | Filing → |
| NBIX | SELL | 2023-01-05 | $3.6M | — | Filing → |
| NBIX | SELL | 2022-01-26 | $1.1M | — | Filing → |